StockTake: $3M for Euro market push

Bioxyne’s latest capital raise has proved fruitful, filling the company’s coffers ahead of its push into European markets.

Bioxyne's (ASX:BXN) latest $3 million capital raise has gained piqued interest from new and existing institutional investors globally.

The over subscribed raise will fill the company's coffers, enabling it to build medical cannabis manufacturing facilities across key European markets.

Watch the video for the latest.

This video was developed in collaboration with Bioxyne, a Stockhead advertiser at the time of publishing.

This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

Originally published as StockTake: $3M for Euro market push